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Abstract
Background: While feasibility of new health technologies in well-resourced healthcare settings is extensively
documented, it is largely unknown in low-resourced settings. Uganda’s decision to deploy and scale up malaria
rapid diagnostic tests (mRDTs) in public health facilities and at the community level provides a useful entry point
for documenting field experience, acceptance, and predictive variables for technology acceptance and use. These
findings are important in informing implementation of new health technologies, plans, and budgets in low-
resourced national disease control programmes.
Methods: A cross-sectional qualitative descriptive study at 21 health centres in Uganda was undertaken in 2007 to
elucidate the barriers and facilitators in the introduction of mRDTs as a new diagnostic technology at lower-level
health facilities. Pre-tested interview questionnaires were administered through pre-structured patient exit
interviews and semi-structured health worker interviews to gain an understanding of the response to this
implementation. A conceptual framework on technology acceptance and use was adapted for this study and used
to prepare the questionnaires. Thematic analysis was used to generate themes from the data.
Results: A total of 52 of 57 health workers (92%) reported a belief that a positive mRDT result was true, although
only 41 of 57 (64%) believed that treatment with anti-malarials was justified for every positive mRDT case. Of the
same health workers, only 49% believed that a negative mRDT result was truly negative. Factors linked to these
findings were related to mRDT acceptance and use, including the design and characteristics of the device,
availability and quality of mRDT ancillary supplies, health worker capacity to investigate febrile cases testing
negative with the device and provide appropriate treatment, availability of effective malaria treatments, reliability of
the health commodity supply chain, existing national policy recommendations, individual health worker dynamism,
and vitality of supervision.
Conclusions: mRDTs were found to be acceptable to and used by the target users, provided clear policy
guidelines exist, ancillary tools are easy to use and health supplies beyond the diagnostic tools are met. Based on
our results, health workers’ needs for comprehensive case management should be met, and specific guidance for
managing febrile patients with negative test outcomes should be provided alongside the new health technology.
The extent, to which the implementation process of mRDT-led, parasite-based diagnosis accommodates end user
beliefs, attitudes, perceptions, and satisfaction, as well as technology learnability and suitability, influences the level
of acceptance and use of mRDTs. The effectiveness of the health system in providing the enabling environment
and the integration of the diagnostic tool into routine service delivery is critical.
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Background
The benefits of malaria rapid diagnostic test (mRDT)
technologies are well documented [1,2] and globally
acknowledged. World Health Organisation (WHO) has
endorsed mRDTs as adjunct tests to microscopy for
parasitological confirmation of malaria in routine fever
case management at lower levels of healthcare [2]. How-
ever, endorsing a new or improved health technology in
itself does not guarantee end-user utilisation, especially
in resource-poor countries where government health
facilities are underfunded, ineffective, or underutilised
[3]. Studies done in settings with well-resourced health
services have reported several factors responsible for
acceptance and use of new digital and health technolo-
gies [4,5]. These factors include organisational features
such as how well the new technology is integrated with
existing technologies, workflow, and top management
commitment to the new technology. Also cited are indi-
vidual factors such as perceptions of negative effects on
users, resistance to change, lack of control, and readi-
ness for change, as well as job factors such as self-effi-
cacy, level of education, previous experience with similar
technology, age, gender, clarity on the reasons for the
new technology, training, and participation. Other fac-
tors reported include the design of guidelines or models
of implementation that accommodate a range of end-
user expectations. There are some discussions that suc-
cessful introduction and uptake should be informed by
credible field experiences and predictive variables for
technology assimilation and acceptance [6,7]. It is not
clear whether similar factors are responsible for assimi-
lation of new technologies such as mRDTs in low-
resource settings.
In most parts of Africa where malaria-like fevers are
responsible for more than 300 million episodes and one
million deaths per year [1,8], parasite-based diagnosis with
low-cost, simple diagnostic tools is recommended to con-
firm or rule out malaria. These technologies, if deployed
and used optimally, should enable targeted treatment of
malaria at lower-level healthcare facilities and at the com-
munity level [2]. In 2006, the National Malaria Control
Programme (NMCP) of the Ministry of Health of Uganda
requested local research groups for evidence to inform a
shift from presumptive to targeted treatment of malaria
using mRDT-led parasitological diagnosis at peripheral
and community levels of healthcare. At the time, micro-
scopy was the recommended form of parasite-based diag-
nosis at facilities with the necessary equipment and
personnel, i.e., hospitals, large health centres grade IV (HC
IV) and some mid-level health centres grade III (HC III).
Clinical diagnosis was recommended for peripheral health
centres grade II (HC II) and presumptive treatment at the
community level by community-based agents (referred to
at the time as community medicine distributors).
NMCP and its stakeholders reviewed the international
and national evidence that was available at the time and
agreed via consensus to go for a phased approach in
deploying mRDTs to a national scale, and in a manner
that complemented microscopy-based diagnosis [9].
This study and other operational research [10] were
conceived and carried out to facilitate evidence-based
policy formulation and high quality implementation of
mRDT-led, parasite-based diagnosis.
This study comprised qualitative and quantitative
descriptive work. The effect of mRDTs on antimalarial
drug prescription practices was assessed using data
extracted from routine health management information
records (HMIS) at health facilities. The findings of this
quantitative part of the study have been reported else-
where [11]. The qualitative aspects reported here sought
first-hand information on the early experiences of health
centre attendees’ and health workers with mRDTs. Spe-
cifically, perceptions, attitudes, beliefs, and practices of
these users were documented and assessed to gain
insight on the barriers and facilitators of acceptance and
use of mRDTs.
Methods
This work involved research embedded [12] into the
implementation process of mRDT-led, parasite-based
diagnosis. The study took place between July and
December 2007, whereas the longer implementation
process started in early 2006. Data were collected using
two sets of surveys targeting health workers and health
centre attendees. A conceptual framework that was
adopted from previous work on technology acceptance
[13] was used to inform the design of the questionnaires
and analysis of the data.
The implementation team
The study implementation team consisted of a clinical
epidemiologist, a parasitologist, and a laboratory tech-
nologist, who provided study oversight, trained health
workers, and provided support supervision. Ten male
and female research assistants with backgrounds in clin-
ical and social sciences were selected and trained to
carry out the interviews. In the choice of research assis-
tants, some experience in qualitative research and flu-
ency in the dialects of interviewees were taken into
consideration. All team members participated in the
pre-testing of the study instruments.
Study design
This was a qualitative descriptive design. Data were col-
lected from a sample of health workers and health cen-
tre attendees in five purposively selected districts,
namely Kapchorwa, Mubende, Iganga, Jinja, and Mbale.
Based on the objectives of the larger study, districts
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were selected to represent the malaria transmission and
rural-urban settings found in the country. In this regard,
Kapchorwa represented a hypo-endemic area with a
malaria parasite prevalence of < 20%; Mubende a
mesoendemic area with a malaria parasite prevalence of
20 to 70%; Iganga a hyper-endemic region with malaria
parasite prevalence of > 70% [14]; Jinja and Mbale were
included to represent a population located in relatively
semi-urbanised areas compared to the other districts
that were relatively more rural. These stratifications
were considered important to better contextualise the
findings, but have not been used in this paper.
For inclusion, HCs had to be part of the public
healthcare sector, not have serological and parasite-
based diagnostic services, and with no previous invol-
vement in medical or operational research. When con-
tacted, the HC in-charges had to express willingness to
participate in the study. With these criteria, five HCs
per district, of types II and III (the average total num-
ber of public HCII and III in our study area was 21 in
Kapchorwa, 49 in Iganga, 48 in Jinja, 35 in Mubende,
14 in Mbale) were randomly selected by the district
health officers within each of the five districts for the
study. Of these, one HC per district was randomly
allocated to be a comparator HC without mRDT-led,
parasite-based diagnosis. However, one comparator HC
in Iganga district was converted to an implementation
HC, after mRDTs were introduced in August 2007 by
another partner organisation operating in the district.
To replace this, another HC was purposively selected
by the malaria focal person in the district to be the
comparator. In this way, 21 health centres where
mRDTs were deployed formed the study sample for
this component of the research.
The implementation process involved mRDT selection
and deployment, community sensitisation, and health
worker training and supervision. These steps are
described below.
mRDT selection
Given the predominance of P. falciparum as the cause
of malaria in this setting, it was decided to use a histi-
dine rich protein-2 (HRP2) type of mRDT. In deciding
the mRDT brand to use, a basic assessment of ease-
of-use was carried out on four brands amongst nine
health workers at a health centre not involved in this
study. The ICT Pf brand was chosen on the basis of
packaging and labelling, ease of performance, readabil-
ity of the results, cost, heat stability data, and reported
sensitivity and specificity. The accuracy of the ICT Pf
brand had earlier been established in Uganda [15],
and the study findings were used to inform training as
well as boost health workers ’ confidence in the
mRDT.
mRDT deployment
mRDTs were quantified, procured, handled, and stored
safely by Malaria Consortium before delivery to imple-
menting HCs in Mbale, Kapchorwa, and Mubende dis-
tricts in June 2007. Job aids and ancillary supplies such
as cotton wool, timers (wall clocks), indelible markers
for labelling, sharps containers, and disposal bins were
provided alongside mRDTs. Iganga and Jinja districts
mRDTs received mRDTs supplies without gloves, clocks,
sharps boxes, and indelible markers two weeks after the
initial districts. In-charge health workers in the latter
HCs were encouraged to order these supplies through
the routine district medical supplies system. Their
efforts to do so were not successful, and as a result
these additional items were supplied about two weeks
later. The delay in distributing these items to these
areas provided the opportunity to observe what effect
the provision or lack of mRDT ancillary supplies had on
health workers’ decisions on whether or not to use
mRDTs.
Community sensitisation
Prior to health worker training, the district health teams
and local public opinion leaders were informed about
this study. Opinion leaders were given the chance to
discuss issues related to the research. The purpose of
this process was to garner their support for the work
and make them aware of the benefits of better malaria
diagnosis in fever case management.
Training of health workers
Guided by an earlier version of the WHO generic
mRDT trainers’ manual [16], a one-day, hospital-based
training for district officials and health workers was con-
ducted at larger HC IV facilities in the participating dis-
tricts. Trainers, comprised of three study team
supervisors and one technical member of the National
Malaria Control Programme, taught HWs how to per-
form, interpret, and utilise mRDTs in fever case man-
agement. A script concordance test (SCT) [17] was used
to evaluate the degree of concordance between health
workers proficiency in performing a mRDT and the pic-
torial job aid with step-by-step instructions. At the end
of the training session, each health worker was observed
performing three mRDTs and an average SCT score cal-
culated. A priori, the health workers were not informed
that a SCT on their practice would take place. However,
health workers were informed about the interviews as
part of the upcoming data collection process. It was
only after trainers had observed trainees performing the
tests and interpreting the results that coaching was
given to mitigate any errors. A score of 95% (one out of
15 steps skipped or poorly performed) and above
reflected a high degree of concordance corresponding to
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optimal mRDT use. This was set as the minimum toler-
able performance on an average of three tests performed
per health worker.
Health worker supervision
For the first eight weeks, supervision occurred at two-
week intervals. Subsequently, supervision took place
once a month. A pre-designed mRDT supervision
checklist was used alongside the national routine techni-
cal supervision tool, which did not have a section on
mRDTs at the time. During supervisory visits, health
workers in implementation HCs were encouraged to use
the diagnostic tool and test results in fever case manage-
ment. During each supervision visit, the SCT was used
to measure the degree of concordance of the health
workers’ knowledge of mRDT job aid instructions and
the efficiency with which this knowledge was translated
into clinical actions. Supervision visits were also used
for data collection.
Conceptual framework
To guide the research, a conceptual framework was
adopted based on earlier models [4,13,18] and publica-
tions [19]. The framework is depicted in Figure 1. In the
framework, feasibility is defined as the process in which
mRDTs are deployed to HCs, leading to their accep-
tance and utilisation by end users. The framework also
recognises that feasibility depends on acceptance and
use factors as well as a host of implementation factors,
such as policy, case management guidelines, supplies,
budgeting, planning, monitoring, and evaluation.
As illustrated in Figure 1, it can be presumed that
mRDT acceptance and use are potentially influenced by
attributes related to users, i.e., health workers and HC
attendees, as well as the diagnostic tool and the health
system. These attributes, including learnability, willing-
ness, suitability, satisfaction, efficacy, and effectiveness
have been identified in other settings [18]. For this
study these attributes were adapted with the meanings
below;
1. Learnability: ability of the health worker to under-
stand how to correctly perform the mRDT, a new
health technology, and accurately read the test
results.
2. Willingness: health worker intention to carry out a
blood test each time it is necessary, wait for the
results, and prescribe medication (or not) in line
with national guidance and test results. Regarding
the HC attendee, willingness was defined as HC
attendees’ intention to have the test performed on
themselves or their child, wait for test results, and
take medication (or not) in line with the test results.
3. Suitability: health workers’ belief that the test is
relevant for his/her work and that test results are a
true indication of the presence or absence of malaria
parasites. Regarding HC attendees, suitability was
defined as HC attendees’ belief that the test is
Figure 1 Conceptual framework for exploring acceptance and use of malaria rapid diagnostic tests when introduced in public sector
lower level health centers in Uganda, adapted from Jeng J (2004).
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relevant in determining whether or not they or their
child has malaria.
4. Satisfaction: a health worker’s feeling that the test
is convenient to perform and that it is a process he/
she likes doing. Regarding the HC attendee, suitabil-
ity was described as feeling that a test is convenient
to take and that it is a process they would like to
carry out again. It also refers to the ease-of-use of
the mRDT, which is affected by the design of the
mRDT, its labelling, and instructions.
5. Efficacy: that the health worker is able to make
the effort and time to perform a test, read, interpret,
and record test results, as well as prescribe medica-
tion in line with the test results, as part of their
daily routine work.
6. Effectiveness: that the enabling organisational and
supporting systems, such as training, supervision, job
aids, supplies, medicines, space, lighting, timers, sto-
rage, and disposal are present or carried out and are
integrated into existing routine systems.
These attributes work in an interrelated way to contri-
bute to acceptance and use of a new technology. Accep-
tance comprises positive perceptions, beliefs, and
attitudes toward mRDTs and test results among users, i.
e., health workers and health centre attendees. Use
refers to the actions taken by health workers to apply
the tool and its results to achieve specified outcomes. In
turn, if acceptance and use are high, then implementa-
tion is feasible. This conceptual understanding informed
more focused inquiries in the design of the data collec-
tion tools.
Implementation and data collection tools
A WHO training manual and mRDT job aid that were
undergoing review at the time, as well as a modified
NMCP supervision checklist and a SCT were used. A
health worker semi-structured interview guide and a
patient exit (i.e., HC attendee) interview guide were
used for one-to-one interviews administered by research
assistants. The interview guide comprised closed and
open-ended questions that focussed on the study objec-
tives in such a way that these data could be used to gen-
erate information for the thematic analysis informed by
the conceptual framework. All data collection tools were
pretested at Kasangati HC IV, a health facility not parti-
cipating in the study.
Ethical considerations
This research was approved by the NMCP, Ministry of
Health of Uganda, and the Uganda National Council of
Science and Technology (UNCST). The procedures fol-
lowed were in accordance with the Helsinki Declaration.
In addition to asking the HC in-charge for oral consent
for that HC to be included in the study, each health
worker was asked to consent by signing the consent
form to participate in the study. The HC attendees’ con-
sent was obtained by a research assistant before the exit
interview. The consenting process for both health work-
ers and HC attendees included an explanation of the
study, its objectives, potential benefits and risks, and the
contact information of the study PI. The HC attendees




Following mRDT deployment, interviews were con-
ducted on a monthly basis using semi-structured inter-
view guides designed to get a broad insight into mRDTs
and parasite-based diagnosis. Open-ended interview
questions were administered by study clinical and social
work research assistants. The first of four rounds of
interviews were conducted with health workers who had
given formal consent, six to eight weeks after the initial
deployment of mRDTs in June 2007. Interviews were
conducted at the study HCs during working hours and
in a manner that avoided disruptions to service delivery.
All eligible health workers had a minimum one-month
experience with mRDTs and were involved in fever case
management.
Health centre attendee interviews
The study included all HC attendees who agreed to be
interviewed exiting the study HC after receiving care
from the health workers. At the point of exit, the
attending health worker told the patient about the visit-
ing study team, and that they were interested in talking
to the patient or parent/guardian of the patient younger
than 18 years. Those HC attendees who were 14 to 18
years and visiting the health centre on their own, such
as teenage pregnant girls and mothers, were consented
as unique cases, referred to as emancipated and mature
minors by UNCST. Although the health workers in the
HC knew that the HC attendees were being asked ques-
tions related to mRDTs, they were not aware of the
questions in the HC attendee questionnaire. HC atten-
dees were informed by the research assistants about the
study, the length and format of the interview, terms of
confidentiality, and the right to withdraw consent before
or during the interview. A semi-structured questionnaire
and photographic aids of mRDTs and the first line anti-
malarial medicine, artemether-lumefantrine (AL), were
used to simplify explanations during interviews. The
interview focused on: knowledge and perceptions of
malaria infection; parasite-based diagnosis and treat-
ment; willingness to test and re-test with mRDTs; belief
in the test result; and the HWs decisions on healthcare,
following a blood test for malaria. Discussions with
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interviewees were guided by questions seeking to under-
stand opinions and beliefs about mRDT-led, parasite-
based diagnosis, as well as barriers and facilitators of
mRDTs acceptability.
Quality Assurance
The mRDTs were transported in vehicles that allowed
free flow of air. Manufacturer’s temperature specifica-
tions (4 to 30°C) were monitored and maintained both
at storage and during transportation using log tags. To
enhance clarity, indelible markers were provided to label
the mRDT cassette with patient identifiers, date, and
time when to read the test results. All health workers
retained used mRDT cassettes in the HC during the
study period, because guidance on appropriate disposal
methods was anticipated from national level. Study
research assistants were trained to carry out interviews
and were regularly overseen by three study supervisors
throughout the data collection period. All completed
interview questionnaires were checked for accuracy and
completeness at the end of each month during a health
facility visit by the study statistician.
Data analysis
Thematic analysis using a realist method was used to
generate themes on the acceptance and use of mRDTs
among respondents. This process started with the man-
ual transcription of all the qualitative data from com-
pleted interview questionnaires. This step was largely
carried out by the social scientist; the research team
reviewed the transcriptions and through a number of
group discussions identified meaningful patterns in the
data from ideas, views, opinions, perceptions, and beliefs
of respondents. These patterns were annotated with
numerical codes. They were reviewed and assessed in
line with the attributes of the conceptual framework to
form themes that related to acceptance and use. The
implications of these themes on implementation feasibil-
ity were used to categorise them into barriers and facili-
tators. With regard to the quantitative data, which relate
more to mRDT use, the effect of mRDTs on anti-malar-
ial drug (AMD) prescription was quantified by comput-
ing risk ratios for the two analysis designs (pre-post and
intervention-control), after adjusting for clustering in
health facilities using survey data analysis methods in
STATA 10. This quantitative information is presented
elsewhere [11].
Results
As part of the implementation process, 129 health work-
ers, of 135 who were eligible, were trained to perform
mRDTs and utilise test results in fever case manage-
ment. Of those who completed training, 74 were clinical
officers, six were laboratory technicians, seven were
records assistants, and 42 were general service support
staff such as health educators, nursing assistants, and
vaccinators. Six health workers that had missed the
initial training session received on-the-job training dur-
ing the first supervisory visit, one month (i.e., in August)
after mRDT deployment.
A total of 102 health workers (76% of all eligible
health workers trained centrally and on site) consented
to be interviewed. The remaining 33 health workers
were not available at their stations at the time of the
interview for various reasons. During the study period,
complete interviews were carried out with 63 of 102
(62%) health workers because some of those who gave
their consent were not able to take part in the inter-
views due to a number of reasons. The main reasons for
non-participation after consenting were that the health
worker had to attend to patients who arrived before or
during the interview and some health workers felt that
one month of mRDT implementation was not enough
for them to have sufficient experience with mRDTs to
answer the questions.
A total of 1,068 patients (829 adult patients and par-
ents/guardians of 239 children age five years or younger)
were interviewed at exit following care at health centres
where mRDT-led, parasite-based diagnosis was intro-
duced. The majority of HC attendees interviewed, 65%,
were female (697 mothers and 70 guardians). The find-
ings presented here are limited to the 97% (1,035/1,068)
of the HC attendees who actually completed the inter-
views. The key findings are presented here as themes
and discussed. Acceptance and use barriers and facilita-
tors are illustrated at end.
Health Worker experiences related to mRDTs deployment
Adherence to the mRDT job aid
During the pre-deployment training session, health
workers generally perceived the mRDT job aid as a use-
ful tool. A total of 54% (70/129) of health workers cor-
rectly carried out all 15 steps in the mRDT job aid, or
missed only one. Some health workers skipped more
than one instruction or performed the mRDT without
the job aid. SCT findings indicated that the instruction
that proved to be most difficult was pipetting blood
using the Pf mRDT ICT™ blood transfer device. Only
18/63 health workers drew blood accurately during the
first supervision, three weeks after deployment. Other
common errors included using an incorrect number of
drops of running buffer (43/63 health workers), forget-
ting to clean the finger with alcohol swab before making
the finger prick (47/63 health workers), reading the test
results at an incorrect time (45/63 health workers) or
forgetting to check the expiry date on the test kit.
Although similar remarks such as, ‘RDTs are good if
you are still young. With old age, you shake and you
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cannot do it. It is also hard to tell the mark of the test
and control lines if it is not bright outside’ were made
by some elderly health workers in Jinja and Kapchorwa,
by the second round of supervision, six weeks later, 32
(51%) health workers who found it hard to use the
blood collecting device had become familiar with it.
Characteristics of the mRDT kit
The ICT Pf. blood collection device proved difficult to
use mainly because of the skill needed to pipette 5 μl of
blood accurately. Interpreting the mRDT expiry date on
the package seemed to be a common challenge at all
health centres. It was not clear to them because the date
indicated only the month and year as 12/2007. Some
health workers interpreted this as expiring on the first
day of the month whereas others decided that the
mRDT expired on the last day of the month. A male
laboratory staff member at a HC III, Mbale District, rea-
soned that, ‘You know the antigen in the RDT is a pro-
tein, which is unstable in our conditions. I think it is
better not to stretch the expiry date further than the
first date of the month.’
Some health workers perceived a faint mRDT test line as
signifying less malaria infection than a bold test line. These
health workers reported that children were more likely to
have bold test lines than adult patients. A male health
worker at HC III, Kapchorwa District explained that, ‘we
have noted that adult patients have a faint positive test
line unlike children, so we give the old people CQ [chloro-
quine] and the young ones get Coartem [AL] yellow.
Otherwise we would have to combine the Coartem [AL]
yellow for the adults and it would run out quickly.’
Some of the laboratory technicians expressed concern
that mRDTs are not able to quantify malaria parasites
and that very low density antigenemia could be unde-
tected by mRDTs and lead to severe forms of malaria in
patients with false negative results. A laboratory assis-
tant at a HC III in Mbale said that, ‘RDTs cannot tell
you the severity of malaria, so we just take precaution
and treat or I send the patient for microscopy.’
Satisfaction with the mRDT
Two months after introducing the new health technol-
ogy to the health centres, 57 (90%) health workers
reported enthusiasm to use mRDTs on a daily basis and
felt that mRDTs were relevant tools for fever case man-
agement. It emerged that the health workers at 12 of 21
HCs felt that health centre attendees had more confi-
dence and respect in them because of their capacity to
perform the test. For example, an in-charge from a HC
III in Mubende district reported that, ‘the community
now has confidence in us and the services we offer
because of the RDTs.’
Another in-charge from a HC III, in Mbale district
said, ‘with blood tests, we can now confidently tell that
the patient is not suffering from malaria.’
One other perceived benefit of the diagnostic tool was
that it allowed the health workers to monitor the effect
of malaria interventions such as distribution of long-
lasting insecticide treated nets (LLINs) and the use of
indoor residual spraying (IRS). An in-charge in
Mubende District mentioned that, ‘with RDTs, we can
now see the impact of spraying mosquitoes and distri-
buting bed nets. Malaria cases are very low.’
Work and organisational environment
The small size and nature of the alcohol swabs supplied
with the mRDT kit seemed to pose a challenge because
one swab was not sufficient to clean soiled hands, which
can be common in rural agricultural settings. Without
adequate clean tap water at the HCs, health workers
were often faced with a situation in which they are
expected to perform mRDTs on patients presenting
with soiled fingers without the means to clean them
properly. In this study, we provided cotton wool to sup-
plement the small and thin alcohol swabs supplied with
the mRDT. It was common for health workers not to
have a wristwatch or wall clock to time the testing pro-
cess, and yet they were trained to use a timer for the
process.
There was the perception that mRDTs placed addi-
tional pressure on health workers due to community
demand for the new diagnostic tool. A HC III in Iganga
district, which was manned by four health workers
decided to charge a fee (equivalent to about $0.20) for
each mRDT performed as a way of controlling patient
demand. The in-charge confirmed this, after a female
health centre attendee inquired during an exit interview,
‘Musawo (health worker) told us that in order to have a
malaria blood test, we have to pay 500 shillings, which
help him to bring in more tests. Is this true?’
Noteworthy, 74% (47/63) of all health workers thought
it wasteful to change gloves from one patient to the
next. Overall, 57% (36/63) reported failure to regularly
perform the test due to programmatic constraints, such
as lack of ancillary supplies, heavy workload, inadequate
staffing, and unclear national guidelines.
Treatment practices in the context of mRDT results
Regarding choices to treat patients based on test results,
only 57 of 74 of the clinical health workers accepted to
address this question, and the other 20 were non-com-
mittal. About 75% (43/57) reported consistent utilisation
of the mRDT results when managing patients with sus-
pected malaria infection. A total of 16 of 57 (28%)
reported that they would not necessarily treat every
patient testing positive with anti-malarials. A total of 23
of 57 (40%) mentioned that they do not rule out pre-
scribing antimalarial medicine to a patient testing nega-
tive for malaria infection with a mRDT. Some health
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workers said that they prescribed non-ACT malaria
treatment to HC attendees above five years of age with
a positive mRDT result in order to preserve ACTs for
patients aged below five years. The non-ACTs pre-
scribed as first line treatment for malaria were quinine,
CQ, or sulphadoxine-pyrimethamine.
The proportion of health workers that did not pre-
scribe ACT or non-ACT anti-malarials to patients test-
ing negative or ‘slightly’ positive, gave folic acid,
multivitamins, or analgesics. This category of health
workers reasoned that they were saving ACT for those
who were mRDT positive and still meeting the expecta-
tions of patients who insisted on getting a treatment for
their complaints.
A female nurse at HC III, Mubende district said, ‘in
case of pending stock outs, negative RDT adult patients
and slightly positive RDT patients get CQ/SP, in order
to save Coartem for children.’
A male in-charge at a HC III in Mubende District
articulated that, ‘children get Coartem [AL] even if they
test negative, according to policy.’
Another one from a HC III in Mubende said, ’my jud-
gement as a clinician guides my treatment decision
when the RDT is negative. Patients expect us to treat
them regardless of RDT result.
A female nurse at HC III, in Mubende district
reported that, ‘we prescribe multivitamins, paracetamol
or folic acid to adult patients with negative RDT results.
In case of pending stock outs for Coartem, negative
RDT adult patients and slightly positive RDT patients
get CQ/SP, in order to save Coartem for children.’
HC attendee experiences related to mRDT deployment
Willingness to have a test
More than 94% (977/1035) of HC attendees who com-
pleted the interviews mentioned willingness to have a
mRDT performed on them or their children. About 3%
of health centre attendees interviewed (36 respondents)
were reluctant to take the test despite having never
experienced the procedure before. Some respondents
(59%) who were willing to take a blood test believed
that they were justified to challenge or reject a negative
mRDT result, if it was not associated with a drug pre-
scription. The expectation of an antimalarial drug pre-
scription despite a negative mRDT result was noted
among some respondents in all implementation health
centres. This was best expressed by a male health centre
attendee at a HC III, Mubende District who said, ‘I like
the idea of taking a blood test, but I still need to get
treated even if the test says I have no malaria. Would I
have come to the clinic if I was healthy?’
Other reasons influencing willingness to accept a
mRDT were related to gender, spiritual, and traditional
beliefs. A mother with child at HC II, Jinja District said,
‘I need my husband to allow me to give the child’s
blood for testing.’ A family head attending with family
at HC III, Mubende District said, ‘my religion does not
permit us to give blood.’ And an elderly woman attend-
ing a HC II, Jinja District remarked that, ‘I cannot tell
where my blood will end up, since it is placed in a con-
tainer and retained.’
Willingness to wait for the test result
Asked if attendees were willing to spend longer than the
usual waiting time at the HC as a result of the mRDT
procedure, 99% (of those willing to take the blood test)
said they were willing to wait for the mRDT result if
they had to. Lack of confidence in the mRDT result, dis-
satisfaction with the decision of the health worker not to
give malaria treatment, or fear of the pain of the finger
prick were the main reasons for reluctance to have a
test done. Some patients considered testing as a waste
of time, or perceived the test results as false, preferring
to believe that malaria was the cause of the febrile
illness.
Discussion
This study provides the first documentation of imple-
mentation feasibility and in-depth account of acceptance
and use of mRDTs and test results in fever case man-
agement at lower level health facilities in Uganda. It
provides a rich source of information that is of benefit
to policy makers and implementers because it was car-
ried out in typical programmatic settings and in differ-
ent geographical locations. The results demonstrate the
multifactorial nature of introducing new health technol-
ogies in resource-limited settings and highlight some
beliefs, perceptions, and reasons for adhering or disre-
garding test results in malaria case management. To
some extent, these findings are similar to other reports
in well-resourced settings, in that acceptance and use of
a new digital or health technology depends on a host of
implementation issues, as well as individual, cultural,
and organisational factors [4,13,18,20]. The findings
from this study suggest that the introduction and scaling
up of new health technologies in Uganda require a spe-
cific policy framework and that implementation models
address more than the common issues of health worker
training, commodity distribution, and support
supervision.
The conceptual framework that was adopted to inform
our inquiries helped to elucidate the broader contextual
issues. These considerations include: the design and
characteristics of the mRDT (which contribute to learn-
ability and suitability); the availability and quality of
ancillary supplies for performing the mRDT (which con-
tribute to effectiveness); health worker capacity to inves-
tigate mRDT negative febrile cases and provide
appropriate treatment (efficacy and effectiveness);
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availability of effective malaria treatments (effectiveness);
reliability of the health commodity supply chain (effec-
tiveness); and dissemination of policy recommendations
(effectiveness); individual dynamism (efficacy); vitality of
supervision and feedback (effectiveness); and strategic
approaches that support integration of new tools into
existing systems without jeopardising health worker’s
perceived sense of respect (satisfaction and efficacy)
among health centre attendees.
The findings that health workers perceived mRDTs as
a symbol of professionalism in healthcare and a majority
of HC attendees associated the mRDT with quality care
by the health worker who performed the mRDT are
potentially a significant indication of the perceived role
of this new point-of-care health technology.
Some health workers felt the mRDT was an empower-
ing tool that enabled them to engage patients in the
decision making regarding their treatment. This prob-
ably implied a sense of confidence to both the health
worker and HC attendee when compared to the process
of clinical diagnosis or presumptive treatment that
mainly relies on the health worker’s judgement. The
relevance of patient involvement in decision making and
health workers interpersonal skills in enhancing patient
willingness to test has been recognised before [4,6]. It is
likely that if prestige and patient confidence are asso-
ciated with a new health technology such as the mRDT,
acceptability is more likely to occur.
On the other hand, some health workers reported the
restrictive nature of test results in clinical judgement,
based on their perceptions that the new diagnostic tool
imposed on them treatment decisions contrary what
experience had taught them. The new tool seemed to
pose a threat to health workers’ capacity to make indivi-
dual clinical judgments, which would in turn undermine
health workers’ credibility amongst their patients. This
perception is noteworthy, particularly because the
majority of the HCs attendees (98%) did indeed report
that they had inquired about their test result. These
facts suggest that the decision making process could no
longer be monopolised by the health worker. One may
want to consider the challenge of a new health technol-
ogy that is perceived to undermine health workers’ con-
fidence and social status as a potential barrier to
acceptance and use. This is a new diagnostic approach
for health workers and their patients. It has been com-
mon practice over many years that the main cause of
fever is malaria, and therefore clinical judgement and
presumptive treatment have been the most appropriate
way to handle fever cases.
Inconsistencies in policies and treatment guidelines
were mentioned as a contributory factor for health
workers’ misconception of the role of mRDTs in fever
case management. At the time of this study, the policy
for malaria control and prevention in Uganda stated
that, ‘any patient with a history of fever within the last
24 hours without evidence of other diseases should be
treated for malaria even with a negative blood smear for
malaria parasites.... Given the current limitations of
RDTs, their use should be considered only in special
situations (epidemics, children under four months of
age); and their routine use is therefore not recom-
mended’ [9].
Health workers’ view on inconsistent policy guidelines
is in concordance with earlier reports that associated
ambiguous or lack of relevant health policies with poor
use of malaria parasite-based diagnostic tools [21-24]. It
is highly probable that regardless of the resource set-
tings, supportive policies and guidelines play a major
role in the acceptance of new health technologies and,
in this case, use of test results.
Deploying the new diagnostic tool exposed some
obstacles and opportunities resulting from inconsisten-
cies in the pharmaceutical supply chain. The mRDT
tool seemed to provide a practical way of targeting
treatment and rationing ACT medicines for patients
perceived to need them more with or without regard to
the test result. In situations where ACT shortages were
anticipated or present, health workers devised ways of
preventing such shortages. For example, some health
workers reported that some patients were given non-
ACT malaria treatment CQ or sulfadoxine-pyrimetha-
mine (SP), while others received folic acid, multivita-
mins, or analgesics. In this way, the health workers felt
they could save ACT for those who were mRDT posi-
tive, and yet meet the expectations of patients who
insisted on getting a treatment for their complaints.
Some of the decisions taken were to prescribe non-
recommended anti-malarials to those that were mRDT
negative or to limit ACT to children aged less than five
years. It is possible that some health workers felt the
need to conform to patient expectations of a medical
prescription. This means that optimal mRDT utilisation
and adherence to test results can only be achieved if
there is predictable and uninterruptible supply of the
recommended treatments at all levels of healthcare.
The inability of mRDTs to quantify disease and pre-
dict the severity of disease may be a limitation worth
addressing in health worker training and quality assur-
ance programme planning. This limitation was men-
tioned by some health workers, particularly those with a
background in laboratory-based diagnostic services. If a
test resulted in a negative result, some health worker
respondents (who did not believe that all mRDT nega-
tive results were truly negative) perceived that the host
immunity of adult patients prevented the mRDT from
detecting low levels of the parasite. The same health
workers perceived that mRDTs could not detect other
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forms of Plasmodium sp., which were thought to exist in
some epidemiological zones in Uganda. The misinter-
pretation of weak positive mRDT test lines as signifying
less malaria was worrying; it may be related to the
knowledge that malaria parasitaemia can be quantified
using microscopy, and probably related to lack of under-
standing of the reason for varied test band colour inten-
sities. These perceptions and beliefs, as well as concerns
related to reliability of test results, emphasise the need
for detailed information from manufacturers and a
robust quality assurance system when new health tech-
nologies are introduced. Health workers’ fears of poten-
tial risks associated with perceived ‘low undetectable’
parasite densities progressing to severe malaria should
not be ignored in training aids, training sessions, and
support supervision.
Although a one-day training period suggested by an
earlier draft of the WHO mRDT training manual [16]
may be deemed insufficient for comprehensive fever
case management training, our trainees benefited from
utilising hospital settings where there was opportunity
for immediate expert feedback and practical sessions.
Problem identification and solutions were possible in
real time. Our observations indicate that performing
mRDTs is relatively easy to learn, as earlier reported
[11,25]. Supervision is required to coach health workers
in correcting errors identified, based on recommended
national guidance. However, this kind of supervision, i.
e., on-the-job coaching, was not part of routine supervi-
sion. This challenge should be mitigated through com-
prehensive training of trainers and supervisors beyond
technical subject matter and should include adult learn-
ing techniques.
Results obtained from interviews with HC attendees
seem to suggest that accepting to use the new diagnostic
tool technology is reliant on medical prescription after
Figure 2 Illustration of key facilitators and barriers of the acceptance and use of mRDTs in the early implementation of parasite-based
diagnosis in public sector lower level health centres in Uganda.
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testing, regardless of the test outcome. This may be
influenced by a perceived benefit of a treatment after a
test or a tradition of associating health centres with
medication. Accepting to take a mRDT and then leaving
the HC without medicine, in case of a negative mRDT
result, was difficult to comprehend and accept by the
HC attendees. This reasoning is also probably a mindset
arising from the standard of care over the years of pre-
sumptive treatment of fevers [21-24]. This expectation
may take some time and effort to change.
From a programmatic perspective, these findings seem
to suggest other potential barriers and facilitators for
successful implementation of mRDT-led, parasite-based
diagnosis in resource-limited settings that may apply to
other new health technologies; see Figure 2 for a sum-
mary of these. Although earlier reports [6,26,27] identi-
fied some factors affecting new health technology use in
different settings, barriers and facilitators for accepting
the new tool and test results were unknown in Uganda.
In addition, this study identified similar factors for
acceptance and use of new health technologies reported
in well-resourced settings [5,6,27]. Our findings contri-
bute to the body of evidence on new health technology
acceptance and use, as well as factors determining opti-
mal utilisation of test results in a resource-limited set-
ting. The evidence provides an opportunity for further
adaptation of a conceptual framework for mRDT accep-
tance and use in programmatic settings. The quality of
introduction and implementation of other new health
technologies can benefit from this and similar evidence.
One limitation of this study is that the findings are
based on early experiences, which may not have allowed
sufficient time for the respondents to form their opi-
nions or make up their minds on the role of mRDT-led,
parasite-based diagnosis. The effect of mRDTs on
demand for diagnostic services and health facility atten-
dance could not be ascertained during the study period
with this design. Another limitation is that these data
are of reported responses, which could mean that there
is some degree of measurement error and social desir-
ability bias. Despite these, the findings do contribute to
other efforts seeking to inform successful introduction
and adoption of new health technologies in resource-
limited settings.
Conclusions
This study provides an account of early experiences
related to mRDT-led, parasite-based diagnosis among
health workers and HC attendees at the frontline of the
healthcare system. It was possible to illustrate the find-
ings as barriers and facilitators for mRDT acceptance
and use, which in turn affect feasible implementation of
mRDT-led, parasite-based diagnosis. The findings indi-
cate that mRDT acceptance and use is not only
dependent on the perceived medical usefulness and
availability of the tool, but also on the contribution that
mRDTs make to intricate socio-cultural needs. These
findings provide useful insights that can enhance the
effectiveness of introducing new health technologies,
such as mRDTs, at the level of peripheral health services
in Uganda and other similar settings. Based on these
early experiences, there are signs that mRDT-led, para-
site-based diagnosis is feasible to implement with proper
planning and careful consideration of a variety of factors
that affect acceptance and use of this new diagnostic
tool.
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